Document ID: chunk:federal_register_of_legislation:F2018N00171:front:0:p2
Version: federal_register_of_legislation:F2018N00171
Segment Type: other
Provision Reference: 
Character Range: 2677–3415

price of the brand of pharmaceutical item specified in item 2 in the table in Part 2 of the Schedule that comes into force on 1 December 2018 is to be worked out using a reduction of 20%.
  Note: Subsection 99ACB(6A) enables the Minister to determine that limit on the maximum agreed price of a new brand of an existing pharmaceutical item is to be calculated using a lower percentage, including zero %, than would otherwise be the case.

Schedule
Part 1 — Brands of pharmaceutical items with approved ex-manufacturer price not reduced

Column 1  Column 2
Item      Brand of Pharmaceutical Item
          Drug                          Form                                                                    Manner of administration  Brand